VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LKFT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LKFTLakefront Biotherapeutics N.V.
$34.39$2.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksLKFTInstitutional Holders

LKFT logoLakefront Biotherapeutics N.V. (LKFT) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership increased this quarter (+1.18 pp), though top 10 holders maintain a highly concentrated 94.7% of institutional value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
49.6%$973M total value · ▲ +1.18 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
67 / 100
Bullish
Institutions & Flow79 holders-12 net flow (+9 / -21)

AI Insights & Key Takeaways

  • Negative Institutional Flow (-12)
  • Marquee funds including Susquehanna International Group, Llp and Renaissance Technologies Llc maintain significant positions
  • Top 10 holders control 94.7% of institutional value
  • No Insider Signal

Top Institutional Holders of LKFT

Ranked by reported Q2 2026 13F market value

Top 10 Holders
94.7%
Top 25 Holders
99.3%

Share of total reported institutional value in LKFT held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1GILEAD SCIENCES, INC.16.7M$500.2M0.0%25.514%30.34%
2TANG CAPITAL MANAGEMENT LLC3.8M$113.5M0.0%5.781%5.16%
3Madison Avenue Partners, LP3.4M$103.4M+39.9%5.265%4.45%
4Prosight Management, LP2.0M$61.3M+31.8%3.120%10.56%
5EcoR1 Capital, LLC1.7M$50.0M0.0%2.546%2.43%
6AMERIPRISE FINANCIAL INC1.3M$38.1M-10.7%1.943%0.01%
7SUSQUEHANNA INTERNATIONAL GROUP, LLP601K$18.0M+29.9%0.918%0.00%
8DME Capital Management, LP483K$14.5M0.0%0.737%0.37%
9RENAISSANCE TECHNOLOGIES LLC408K$12.2M+29.3%0.623%0.02%
10BlackRock, Inc.338K$10.1M+8.3%0.516%0.00%
11Point72 Asset Management, L.P.270K$8.1M-18.8%0.412%0.01%
12D. E. Shaw & Co., Inc.198K$5.9M-8.3%0.302%0.00%
13MILLENNIUM MANAGEMENT LLC181K$5.4M+67.8%0.277%0.00%
14UBS Group AG168K$5.0M-4.1%0.257%0.00%
15DAFNA Capital Management LLC130K$3.9M0.0%0.199%0.74%
16CITADEL ADVISORS LLC88K$2.6M-39.8%0.135%0.00%
17TWO SIGMA INVESTMENTS, LP82K$2.5M+216.1%0.125%0.00%
18NORGES BANK77K$2.3M—0.117%0.00%
19ALPS ADVISORS INC66K$2.0M+22.1%0.100%0.01%
20GOLDMAN SACHS GROUP INC57K$1.7M+24.7%0.086%0.00%
21AMERICAN CENTURY COMPANIES INC41K$1.2M+5.2%0.062%0.00%
22BAROMETER CAPITAL MANAGEMENT INC.41K$1.2M+7.1%0.062%0.34%
23MORGAN STANLEY38K$1.1M+41.6%0.057%0.00%
24Schonfeld Strategic Advisors LLC33K$977K—0.050%0.00%
25MARSHALL WACE, LLP32K$971K—0.050%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in LKFT — a direct measure of their conviction.

Quarterly Institutional Activity

Filings activity in LKFT during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers9Added To27Trimmed35Exited21
  • Madison Avenue Partners, LP$103.4M
  • Prosight Management, LP$61.3M
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP$18.0M
  • RENAISSANCE TECHNOLOGIES LLC$12.2M
  • BlackRock, Inc.$10.1M
  • MILLENNIUM MANAGEMENT LLC$5.4M
  • TWO SIGMA INVESTMENTS, LP$2.5M
  • ALPS ADVISORS INC$2.0M
  • GOLDMAN SACHS GROUP INC$1.7M
  • AMERICAN CENTURY COMPANIES INC$1.2M
  • BAROMETER CAPITAL MANAGEMENT INC.$1.2M
  • MORGAN STANLEY$1.1M

LKFT Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 20267912%49.64%+1.18 pp$973M+2.5%
Q1 2026901.1%48.46%+0.79 pp$949M7.9%
Q4 2025912.2%47.67%0.14 pp$1.03B5.5%
Q3 202593+9.4%47.81%+0.14 pp$1.09B+24%
Q2 202585+1.2%47.67%+0.18 pp$878M+12%
Q1 202584+3.7%47.49%+0.39 pp$785M8.2%
Q4 202481+3.8%47.10%+26.64 pp$854M+121%
Q3 202478—20.46%—$387M—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

How LKFT Compares to Peers

Institutional ownership and quarterly buying activity across the largest Immunology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
YARWYarrow Bioscience Inc$145M1.2%47+2
RKTORocket One Inc.$9M7.9%22+3

LKFT — Frequently Asked Questions

Quick answers to the most common questions about buying LKFT stock.

What percentage of LKFT is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Lakefront Biotherapeutics N.V. stands at 49.6%, held across 79 reporting institutions.

Who is the largest institutional holder of LKFT?

GILEAD SCIENCES, INC. is the largest reported institutional holder of LKFT, with approximately 16,707,477 shares worth $0.50B as of Q2 2026.

Is LKFT a hedge fund favorite?

Yes — 6 widely-followed marquee investors appear among the top 25 institutional holders of LKFT, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC.

What is LKFT's Smart Money Score?

Our composite Smart Money Score for LKFT is 67 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought LKFT this quarter?

9 institutions opened new positions in LKFT during Q2 2026, while 21 fully exited. 27 added to existing positions and 35 trimmed.

How is institutional ownership of LKFT changing?

LKFT institutional ownership rose by 1.18 percentage points quarter-over-quarter, with a net change of -11 holders.

How concentrated is LKFT ownership among the top holders?

The top 10 institutions account for 94.7% of all reported 13F value in LKFT, and the top 25 account for 99.3%.

How does LKFT compare to Immunology Biotech on institutional ownership?

Across the largest Immunology Biotech peers, institutional ownership levels are: YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.

Where does this LKFT institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.